Medicare AdvantageCoverageMedium impact
Evaluation and Management (E&M) of Diabetic Peripheral Neuropathy with Loss of Protective Sensation (LOPS)
Independence Blue Cross·PA · Endocrinology, Family Medicine, Internal Medicine +1 more·Medical Policy
Effective date
Jun 29, 2026
We identified it
Jun 16, 2026
Summary
Medicare Advantage policy for E&M of diabetic peripheral neuropathy with LOPS will be archived on June 29, 2026, as the service is now considered standard of care. The policy previously covered E&M services every 6 months for documented diabetic neuropathy with LOPS, but this specific coverage policy will no longer exist.
Action Required
By June 29, 2026: Review billing procedures for diabetic peripheral neuropathy E&M services as the specific Medicare Advantage policy will be archived. Ensure documentation continues to support medical necessity since the service remains standard of care but will no longer have dedicated policy coverage criteria. Billing team should verify alternative coverage pathways for these services.